|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2001)) |
IUPAC Name ![]() |
| (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboximidic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7661 | frovatriptan |
Synonyms ![]() |
| Frova® |
| SB-209509-AX |
| VML-251 |
Database Links ![]() |
|
| CAS Registry No. | 158747-02-5 |
| ChEMBL Ligand | CHEMBL1279 |
| DrugBank Ligand | DB00998 |
| PubChem CID | 77992 |
| Search Google for chemical match using the InChIKey | XPSQPHWEGNHMSK-SECBINFHSA-N |
| Search Google for chemicals with the same backbone | XPSQPHWEGNHMSK |
| Search PubMed clinical trials | frovatriptan |
| Search PubMed titles | frovatriptan |
| Search PubMed titles/abstracts | frovatriptan |
| Wikipedia | Frovatriptan |
| Comments |
| Frovatriptan is a triptan (tryptamine-based) drug. |